Recent Advances in Asthma Management
European Respiratory & Pulmonary Diseases · 2018
DOI: 10.17925/erpd.2018.4.1.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory & Pulmonary Diseases, 2018. Verfasst von Peter J Barnes. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: No funding was received in the publication of this article..
Abstract (Originalsprache)
The treatment of asthma has improved greatly during the last two decades, and deaths from the disease have decreased.1 Despite these advances, many asthma patients fail to achieve optimal asthma control as defined by international guidelines. 2,3 Severe asthma is associated with high risk of exacerbations and death. 4 Definitions of severe asthma vary but, according to European Respiratory Society (ERS)/American Thoracic Society (ATS) and Global Initiative for Asthma (GINA) guidelines, severe asthma is asthma that requires treatment with high doses of inhaled corticosteroids plus a second controller, and/or systemic corticosteroids, to prevent it from becoming uncontrolled, or remains uncontrolled despite this therapy. 2,5 In an expert interview, Professor Barnes discusses the latest advances in the management of both mild and severe asthma.
Förderung
- No funding was received in the publication of this article.
Zitieren
APA
Barnes, P. J. (2018). Recent Advances in Asthma Management. European Respiratory & Pulmonary Diseases. https://doi.org/10.17925/erpd.2018.4.1.15
Vancouver
Barnes PJ. Recent Advances in Asthma Management. European Respiratory & Pulmonary Diseases. 2018. doi:10.17925/erpd.2018.4.1.15
BibTeX
@article{Barnes2018,
author = {Barnes, Peter J},
title = {Recent Advances in Asthma Management},
journal = {European Respiratory & Pulmonary Diseases},
year = {2018},
doi = {10.17925/erpd.2018.4.1.15}
}
EUVIMED